艾美捷科技代理Reddot Biotech品牌。

Reddot Biotech Inc.公司生产：各种ELISA试剂盒、检测试剂盒、货架抗体和分子生物学产品。其中ELISA试剂盒涉及领域包括：癌症研究、心血管研究、

细胞生物学、发育生物学、表观遗传学与核信号转导、免疫、代谢、神经科学、信号转导等；抗体用于癌症研究、心血管研究、细胞生物学、发育生物学、表观遗传学与核信号转导、免疫学、

新陈代谢、微生物学、神经科学、信号转导、干细胞等领域。产品富有特点：

（1）ELISA试剂盒：Reddot Biotech提供种类繁多的ELISA试剂盒，通常具有多种反应性，适用于各种样品类型。

（2）检测试剂盒：提供功能性检测试剂盒，用于测量酶活性、小分子、蛋白质含量等。这些试剂盒易于使用，配有所有必要的试剂，并指定最佳波长来测量结果。从 200多种不同的功能检测

中进行选择，可用于各种样品类型。

（3）抗体：提供广泛的一抗和二抗供研究使用。从多种宿主和反应性中进行选择，经验证可用于 ELISA、蛋白质印迹、流式细胞术、免疫组化、免疫荧光或免疫沉淀等应用。

Alpha Diagnostics是一家总部设在得克萨斯的美国生物技术公司。开发、制造和供应新型诊断和质量控制试剂和测试包，用于人类和动物的基本生物和疾病研究。

Alpha Diagnostic International, Inc. (ADI) is a privately held, U.S. biotechnology company headquartered in San Antonio, Texas.  ADI develops, manufactures, and supplies novel diagnostic and quality control reagents and test kits for use in basic biological and disease research in humans and animals.  An important mission of ADI is to develop and supply diagnostic and validating solutions for promoting global health through improved vaccine therapeutics and mitigating the spread of human and animal diseases.

Alpha Diagnostics公司的主要产品包括：

Custom peptides & Antibodies

Primary Antibodies

Secondary Antibodies

Isotype and Serum Controls

ELISA Kits

ELISA Kits and reagents for Infectious Disease and Vaccine research

ELISA Kits and reagents for Therapeutic mAbs, biosimilars, and proteins

Infectious animal disease reagents for vaccine research

ELISA, Western, LFA, IHC/ICC, and IP reagents

Peptides, Proteins, Enzymes, cDNAs, Aptamers, Adjuvants and ODNs

IHC/ICC Slides and Lysates for Westerns

TruStrip™ Rapid Tests and Sample Transfer Strips

艾美捷科技特约代理Avidity Biosciences公司产品。

Avidity Biosciences公司位于美国加州La Jolla，是一家专门从事抗体寡核苷酸结合物（AOC™）技术开发的生物技术公司，此项技术结合了单抗组织选择性和寡核苷酸疗法的精确性，克服了寡核苷酸给药屏障。

Avidity Biosciences is a privately-held biotech company pioneering Antibody Oligonucleotide Conjugates (AOC™). AOCs combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapeutics to overcome barriers to the delivery of oligonucleotides and target genetic drivers of disease.

Antibody oligonucleotide conjugate (AOC™) technology

Avidity’s antibody oligonucleotide conjugate (AOC™) technology utilizes antibodies to target cells and tissues of interest and facilitate the uptake and internalization of oligonucleotide payloads. By combining the cellular and tissue selectivity of antibodies with the selectivity and efficiency of oligo-based approaches, Avidity has demonstrated modulation of disease-related RNAs in diverse cell types and tissues including muscle, heart, liver, tumors and immune cells.